Pathogenesis, Classification & Clinical Features

Question	Answer
1. Define Gaucher Disease and state its biochemical and genetic defect.	Gaucher disease is the most common Lysosomal Storage Disorder, inherited in an Autosomal Recessive pattern caused by bi-allelic pathogenic mutations in the GBA1 gene on chromosome $1q21$. - Enzymatic Defect: Deficiency of lysosomal Acid Beta-Glucosidase (Glucocerebrosidase). - Consequence: Inability to cleave glucocerebroside (glucosylceramide) into glucose and ceramide. Undigested glycolipid accumulates massively inside the lysosomes of macrophages (mononuclear phagocyte system), transforming them into lipid-engorged Gaucher cells that infiltrate the spleen, liver, bone marrow, and skeleton.
2. Classify Gaucher Disease into its three major clinical subtypes.	1) Type 1 (Non-Neuropathic / Adult / Visceral Type): - Most common ($>90-95\%$ of cases; high prevalence in Ashkenazi Jewish populations). - Characterized by massive splenomegaly, hepatomegaly, hypersplenism (thrombocytopenia, anemia), and skeletal involvement (bone crises, Erlenmeyer flask deformity, fractures). - Complete ABSENCE of primary neurological involvement; normal cognition and life expectancy. 2) Type 2 (Acute Neuropathic / Infantile Type): - Onset in early infancy ($<6\text{ months}$) with rapid neurodegeneration, severe retroflexion of head (hypertonia/opisthotonus), bulbar palsy, stridor, and failure to thrive; universally fatal by $1-2\text{ years}$. 3) Type 3 (Chronic / Subacute Neuropathic / Juvenile Type): - Characterized by visceral disease plus progressive neurological features: Supranuclear horizontal gaze palsy (saccadic slowing), myoclonic epilepsy, ataxia, and dementia.
3. What is the pathognomonic histological appearance of a Gaucher Cell?	In bone marrow, liver, or spleen aspirates, Gaucher cells are large ($20-100\,\mu\text{m}$) histiocytes with an eccentric, round-to-oval nucleus and abundant, pale, fibrillary cytoplasm that classically resembles "wrinkled tissue paper" or "crumpled silk". - The cytoplasm stains strongly positive with Periodic Acid-Schiff (PAS) and is diastase-resistant. - Contains high levels of Tartrate-Resistant Acid Phosphatase (TRAP).
4. What are Gaucher "Bone Crises" and how are they managed?	- Clinical Presentation: Episodes of acute, agonizing, excruciating skeletal pain, most frequently affecting the distal femur, proximal tibia, or hip. Accompanied by localized warmth, swelling, erythema, leukocytosis, and low-grade fever, frequently misdiagnosed as acute bacterial osteomyelitis. - Pathophysiology: Caused by massive intramedullary accumulation of Gaucher cells causing acute bone marrow ischemia, venous thrombosis, cortical microfractures, and focal bone infarction. - Management: Immediate high-dose scheduled analgesia (Paracetamol + Opioids like Tramadol or IV Morphine), absolute bed rest, limb immobilization, and aggressive hydration. Perform MRI and blood cultures/CRP to definitively exclude septic osteomyelitis.
5. VIVA TRAP: What is the "Erlenmeyer Flask Deformity"?	The Erlenmeyer flask deformity is a classical radiographic sign seen on plain X-rays of the distal femur. It represents flaring and loss of the normal concave diaphyseal-metaphyseal curve of the distal femur, resulting from massive infiltration of Gaucher cells within the medullary canal which prevents normal osteoclastic cortical remodelling during longitudinal bone growth. Examiner Counter-Question: What are other causes of Erlenmeyer flask deformity? Osteopetrosis (marble bone disease), Niemann-Pick disease, Craniometaphyseal dysplasia, and Thalassemia major.

Diagnostics & Enzyme Replacement Therapy (ERT)

Question	Answer
6. What is the Gold Standard for diagnosing Gaucher Disease? Is Bone Marrow Biopsy required?	- Gold Standard Test: Measuring Beta-Glucosidase (Glucocerebrosidase) Enzyme Activity in peripheral blood leukocytes or dried blood spots (DBS). Activity is severely depressed at $<15\%$ of normal control mean. - VIVA TRAP: Bone Marrow Aspiration is NOT REQUIRED and should NOT be performed if the enzyme assay is available! Bone marrow aspiration is invasive, carries bleeding risk, and can produce false-negative results or false-positive pseudo-Gaucher cells (seen in CML, lymphoma, and multiple myeloma).
7. Name the key monitoring biomarkers used in Gaucher Disease.	1) Serum Glucosylsphingosine (Lyso-Gb1): The most sensitive and specific biomarker for diagnosis and monitoring therapeutic response; correlates directly with visceral and bone marrow storage burden. 2) Serum Chitotriosidase: Markedly elevated ($>100-1000\text{ fold}$); secreted by activated Gaucher macrophages. (Note: $5-10\%$ of individuals have homozygous null mutations in the CHIT1 gene and are chitotriosidase-deficient). 3) Serum Ferritin: Elevated due to macrophage activation. 4) Tartrate-Resistant Acid Phosphatase (TRAP): Elevated.
8. Detail the Enzyme Replacement Therapy (ERT) regimen for Type 1 Gaucher Disease.	- Agents: Imiglucerase (Cerezyme) or Velaglucerase alfa (VPRIV) (recombinant human acid $\beta$-glucosidase targeting macrophage mannose receptors). - Induction Dosage: $30-60\text{ Units/kg}$ intravenously every 2 weeks as an outpatient infusion. - Therapeutic Response: - Normalization of platelet count and resolution of anemia within 6–12 months. - $50-60\%$ reduction in splenic volume and $30-40\%$ reduction in liver volume by 12–24 months. - Cessation of acute bone crises and restoration of normal linear growth. - Substrate Reduction Therapy (SRT): Oral Miglustat or Eliglustat (inhibits glucosylceramide synthase; approved for older patients with Type 1 Gaucher who cannot receive ERT).
9. VIVA TRAP: Why is Splenectomy STRICTLY CONTRAINDICATED in Gaucher Disease?	Historically, splenectomy was performed to relieve cytopenias and mechanical dragging. However, splenectomy is now strictly contraindicated because the massive spleen serves as the primary "shock absorber" or reservoir for the circulating accumulation of glucocerebroside. Disastrous Consequence of Splenectomy: Removal of the spleen shunts toxic lipid accumulation into other non-expandable organs, triggering fulminant hepatic storage (accelerated cirrhosis and liver failure) and catastrophic, crippling bone disease (massive bone marrow infiltration, widespread avascular necrosis, intractable bone crises, and pathological fractures)!
10. Counter-Question Chain: "How do you distinguish Gaucher Disease Type 1 from Niemann-Pick Disease Type B and Visceral Leishmaniasis?"	1) Gaucher Type 1 vs Niemann-Pick Type B: Both have massive hepatosplenomegaly and normal cognition. Gaucher has severe bone crises and Erlenmeyer flask deformity; Niemann-Pick Type B has interstitial lung disease (reticulonodular infiltrates) on chest X-ray and is confirmed by Acid Sphingomyelinase deficiency with sea-blue histiocytes. 2) Gaucher vs Visceral Leishmaniasis (Kala-azar): Kala-azar presents with prolonged undulating fever, hypergammaglobulinemia, dark skin, and positive rK39 strip test; bone crises and Erlenmeyer flask deformity are absent.